NewsBenzinga웨드부시, 아발로 테라퓨틱스에 대한 시장수익률 상회 의견 유지···목표주가 22달러로 하향 조정 웨드부시, 아발로 테라퓨틱스에 대한 시장수익률 상회 의견 유지···목표주가 22달러로 하향 조정 Benzinga 2026.10.23 12:24 (GMT+0) Open on Benzinga Other news QUICK SPARK: Equifax Goes From Its Worst Month on Record to Its Best $100 Invested In Take-Two Interactive 10 Years Ago Would Be Worth This Much Today Wells Fargo Maintains Overweight on Dover, Raises Price Target to $233 Universal Insurance Hldgs Q3 2026 Earnings Call Transcript 'India's Scotch probe of Diageo, Pernod undermining India-UK pact benefits, trade group says' - Reuters Wells Fargo Maintains Overweight on Ryder System, Raises Price Target to $305
'India's Scotch probe of Diageo, Pernod undermining India-UK pact benefits, trade group says' - Reuters
